Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-92,725
Closed -$5.94M 714
2026
Q1
$5.94M Buy
92,725
+13,376
+17% +$1.09M 0.03% 361
2025
Q4
$6.85M Buy
+79,349
New +$6.78M 0.03% 329
2025
Q3
Sell
-7,668
Closed -$538K 689
2025
Q2
$538K Sell
7,668
-39,523
-84% -$2.78M ﹤0.01% 633
2025
Q1
$3.22M Buy
+47,191
New +$3.36M 0.02% 413
2019
Q1
Sell
-6,000
Closed -$391K 821
2018
Q4
$391K Buy
+6,000
New +$395K 0.01% 720
2018
Q3
Sell
-8,642
Closed -$537K 831
2018
Q2
$537K Buy
+8,642
New +$560K 0.01% 690

Other funds holding MMS

Candriam SCA's MMS Position: Q2 2026 in Review

Candriam SCA sold out of Maximus (MMS) in Q2 2026, closing a stake of 92,725 shares — an estimated $5.94M sold.

Candriam SCA first reported a position in MMS in Q2 2018 and held it in 6 quarters. The position peaked at $6.85M in Q4 2025. 349 funds tracked by Wall St. Rank hold MMS as of Q2 2026.

  • Candriam SCA reported no remaining Maximus position as of Q2 2026 after selling out during the quarter.
  • Candriam SCA sold 92,725 Maximus shares in Q2 2026, an estimated $5.94M.
  • Candriam SCA first reported a position in Maximus in Q2 2018 and held it in 6 quarters.
  • Candriam SCA's Maximus position peaked at $6.85M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held Maximus as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.